The function of the adrenocortical axis in permanent middle cerebral artery occlusion: Effect of glucocorticoids on the neurological outcome

Brain Research

Volumn 1407, Issue , 2011, Pages 90-96

  Weidenfeld, J ^a   Leker, R R ^a,b   Gai, N ^a,b   Teichner, A ^a,b   Bener, D ^a   Ovadia, H ^a  

^a Agnes Ginges Center for Human Neurogenetics   (Israel)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Adrenalectomy; Focal cerebral ischemia; Glucocorticoid; Glucocorticoid receptor; HPA axis

Indexed keywords

CORTICOSTERONE; CORTICOTROPIN; DEXAMETHASONE; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; PROSTAGLANDIN E2;

ADRENALECTOMY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INFARCTION; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; CONTROLLED STUDY; CORTICOTROPIN BLOOD LEVEL; CYTOSOLIC FRACTION; ESSENTIAL HYPERTENSION; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; MOTOR DYSFUNCTION; NONHUMAN; PRIORITY JOURNAL; RAT; SHAM PROCEDURE;

ADRENAL CORTEX; ADRENALECTOMY; ADRENOCORTICOTROPIC HORMONE; ANIMALS; ANTI-INFLAMMATORY AGENTS; BRAIN ISCHEMIA; CORTICOSTERONE; CORTICOTROPIN-RELEASING HORMONE; DEXAMETHASONE; DINOPROSTONE; GLUCOCORTICOIDS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; HYPOTHALAMUS; INFARCTION, MIDDLE CEREBRAL ARTERY; LAMENESS, ANIMAL; MALE; MEDIAN EMINENCE; PEPTIDE FRAGMENTS; RATS; RATS, INBRED SHR; RECEPTORS, GLUCOCORTICOID; STROKE; TREATMENT OUTCOME;

RATTUS;

EID: 79961005728     PISSN: 00068993     EISSN: 18726240     Source Type: Journal    
DOI: 10.1016/j.brainres.2011.06.035     Document Type: Article

References (38)

1. Ahmad, M., Saleem, S., Shah, Z., Maruyama, T., Narumiya, S., Dore, S., 2010. The PGE2 EP2 receptor and its selective activation are beneficial against ischemic stroke. Exp. Transl. Stroke Med. 2, 12.
2. Barone, F.C., White, R.F., Spera, P.A., Ellison, J., Currie, R.W., Wang, X., Feuerstein, G.Z., 1998. Ischemic preconditioning and brain tolerance: temporal histological and functional outcomes, protein synthesis requirement, and interleukin-1 receptor antagonist and early gene expression. Stroke 29, 1937-1950 (discussion 1950-1).
3. Bederson, J.B., Pitts, L.H., Tsuji, M., Nishimura, M.C., Davis, R.L., Bartkowski, H., 1986. Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination. Stroke 17, 472-476. (Pubitemid 16085691)
4. Beilin, B., Bessler, H., Papismedov, L., Weinstock, M., Shavit, Y., 2005. Continuous physostigmine combined with morphine-based patient-controlled analgesia in the postoperative period. Acta Anaesthesiol. Scand. 49, 78-84.
5. Bener, D., Wohlman, A., Itzik, A., Yirmiya, R., Ben-Hur, T., Weidenfeld, J., 2007. Glucocorticoid resistance following herpes simplex-1 infection: role of hippocampal glucocorticoid receptors. Neuroendocrinology 85, 207-215. (Pubitemid 47123455)
6. Braughler, J.M., Lainer, M.J., 1986. The effects of large doses of methylprednisolone on neurologic recovery and survival in the Mongolian gerbil following three hours of unilateral carotid occlusion. Cent. Nerv. Syst. Trauma 3, 153-162.
7. Chan, S.J., Wong,W.S.,Wong, P.T., Bian, J.S., 2010. Neuroprotective effects of andrographolide in a rat model of permanent cerebral ischaemia. Br. J. Pharmacol. 161, 668-679.
8. Danton, G.H., Dietrich,W.D., 2003. Inflammatorymechanisms after ischemia and stroke. J. Neuropathol. Exp. Neurol. 62, 127-136.
9. de Courten-Myers, G.M., Kleinholz, M.,Wagner, K.R., Xi, G., Myers, R.E., 1994. Efficacious experimental stroke treatment with high-dose methylprednisolone. Stroke 25, 487-492 (discussion 493).
10. de Kloet, E.R., Oitzl, M.S., Joels, M., 1993. Functional implications of brain corticosteroid receptor diversity. Cell. Mol. Neurobiol. 13, 433-455.
11. De Reuck, J., Vandekerckhove, T., Bosma, G., De Meulemeester, K., Van Landegem, W., De Waele, J., Tack, E., De Koninck, J., 1988. Steroid treatment in acute ischaemic stroke. A comparative retrospective study of 556 cases. Eur. Neurol. 28, 70-72.
12. Dejager, L., Pinheiro, I., Puimege, L., Fan, Y.D., Gremeaux, L., Vankelecom, H., Libert, C., 2010. Increased glucocorticoid receptor expression and activity mediate the LPS resistance of SPRET/EI mice. J. Biol. Chem. 285, 31073-31086.
13. DeKeyser, F.G., Leker, R.R.,Weidenfeld, J., 2000. Activation of the adrenocortical axis by surgical stress: involvement of central norepinephrine and interleukin-1. Neuroimmunomodulation 7, 182-188.
14. Donley, R.F., Sundt Jr., T.M., 1973. The effect of dexamethasone on the edema of focal cerebral ischemia. Stroke 4, 148-155.
15. Dux, E., Ismail, M., Szerdahelyi, P., Joo, F., Dux, L., Koltai, M., Draskoczy, M., 1990. Dexamethasone treatment attenuates the development of ischaemic brain oedema in gerbils. Neuroscience 34, 203-207. (Pubitemid 20097906)
16. Feldman, S., Weidenfeld, J., 1995. Neuralmechanisms involved in the corticosteroid feedback effects on the hypothalamo-pituitary-adrenocortical axis. Prog. Neurobiol. 45, 129-141.
17. Feldman, S., Conforti, N.,Weidenfeld, J., 1995. Limbic pathways and hypothalamic neurotransmittersmediating adrenocortical responses toneural stimuli.Neurosci. Biobehav.Rev. 19, 235-240.
18. Fenske, A., Fischer, M., Regli, F., Hase, U., 1979. The response of focal ischemic cerebral edema to dexamethasone. J. Neurol. 220, 199-209.
19. Goericke, S.L., Engelhorn, T., Forsting, M., Speck, U., Maderwald, S., Ladd,M.E., Doerfler, A., 2010. Intrathecal corticoids in permanent focal cerebral ischemia inrats. Part I: a newtherapeutic approach in the acute phase. J Cereb Blood Flow Metab. 30, 801-807.
20. Herman, J.P., Figueiredo, H., Mueller, N.K., Ulrich-Lai, Y., Ostrander, M.M., Choi, D.C., Cullinan,W.E., 2003. Central mechanisms of stress integration: hierarchical circuitry controlling hypothalamo-pituitary-adrenocortical responsiveness Front. Neuroendocrinol. 24, 151-180.
21. Lee, M.C., Mastri, A.R., Waltz, A.G., Loewenson, R.B., 1974. Ineffectiveness of dexamethasone for treatment of experimental cerebral infarction. Stroke 5, 216-218.
22. Leker, R.R., Shohami, E., 2002. Cerebral ischemia and trauma-different etiologies yet similar mechanisms: neuroprotective opportunities. Brain Res. Brain Res. Rev. 39, 55-73.
23. Leker, R.R., Gai, N., Mechoulam, R., Ovadia, H., 2003. Drug-induced hypothermia reduces ischemic damage: effects of the cannabinoid HU-210. Stroke 34, 2000-2006. (Pubitemid 36944797)
24. Lin, T.N., He, Y.Y., Wu, G., Khan, M., Hsu, C.Y., 1993. Effect of brain edema on infarct volume in a focal cerebral ischemia model in rats. Stroke 24, 117-121. (Pubitemid 23014393)
25. O'Donnell, D., Francis, D., Weaver, S., Meaney, M.J., 1995. Effects of adrenalectomy and corticosterone replacement on glucocorticoid receptor levels in rat brain tissue: a comparison betweenwestern blotting and receptor binding assays. Brain Res. 687, 133-142.
26. Olsson, T., Marklund, N., Gustafson, Y., Nasman, B., 1992. Abnormalities at different levels of the hypothalamic-pituitary-adrenocortical axis early after stroke. Stroke 23, 1573-1576.
27. Ovadia, H., Sobcho, A., Wholmann, A., Weidenfeld, J., 1995. Cellular nuclear binding and retention of glucocorticoids in rat lymphoid cells: effect of long-term adrenalectomy. Neuroimmunomodulation 2, 339-346. (Pubitemid 26233181)
28. Shapira, Y., Davidson, E., Weidenfeld, Y., Cotev, S., Shohami, E., 1988. Dexamethasone and indomethacin do not affect brain edema following head injury in rats. J. Cereb. Blood Flow. Metab. 8, 395-402.
29. Shavit, Y., Weidenfeld, J., DeKeyser, F.G., Fish, G., Wolf, G., Mayburd, E., Meerson, Y., Beilin, B., 2005. Effects of surgical stress on brain prostaglandin E2 production and on the pituitary-adrenal axis: attenuation by preemptive analgesia and by central amygdala lesion. Brain Res. 1047, 10-17. (Pubitemid 40805025)
30. Shohami, E., Shapira, Y., Sidi, A., Cotev, S., 1987. Head injury induces increased prostaglandin synthesis in rat brain. J. Cereb. Blood Flow. Metab. 7, 58-63.
31. Turnbull, A.V., Rivier, C.L., 1999. Regulation of the hypothalamic-pituitary-adrenal axis by cytokines: actions and mechanisms of action. Physiol. Rev. 79, 1-71.
32. Van de Kar, L.D., Blair, M.L., 1999. Forebrain pathwaysmediating stress-induced hormone secretion. Front. Neuroendocrinol. 20, 1-48.
33. Warner, A., Ovadia, H., Tarcic, N., Weidenfeld, J., 2010. The effect of restraint stress on glucocorticoid receptors in mouse spleen lymphocytes: involvement of the sympathetic nervous system. Neuroimmunomodulation 17, 298-304.
34. Weidenfeld, J., Abu-Amer, Y., Shohami, E., 1988. Inhibition of prostaglandin synthesis in brain of rat by dexamethasone: lack of effect of dexamethasone phosphate ester and various hormonal steroids. Neuropharmacology 27, 1295-1299. (Pubitemid 19018317)
35. Weidenfeld, J., Rougeot, C., Dray, F., Feldman, S., 1989. Adrenocortical response following acute neurogenic stimuli is mediated by CRF-41. Neurosci. Lett. 107, 189-194.
36. Weidenfeld, J., Newman, M.E., Itzik, A., Feldman, S., 2005. Adrenocortical axis responses to adrenergic and glutamate stimulation are regulated by the amygdala. Neuroreport 16, 1245-1249. (Pubitemid 41058478)
37. Xiong, X., Liang, Q., Chen, J., Fan, R., Cheng, T., 2009. Proteomics profiling of pituitary, adrenal gland, and splenic lymphocytes in rats with middle cerebral artery occlusion. Biosci. Biotechnol. Biochem. 73, 657-664.
38. Zilberman, Y., Zafrir, E., Ovadia, H., Yefenof, E., Guy, R., Sionov, R.V., 2004. The glucocorticoid receptor mediates the thymic epithelial cell-induced apoptosis of CD4+8+ thymic lymphoma cells. Cell. Immunol. 227, 12-23.